Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Asam Alexander — Mineralys Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Asam Alexander

Asam Alexander

Director at Arcutis Biotherapeutics, Inc. · on record since Jan 30, 2020
Director at Mineralys Therapeutics, Inc. · on record since Feb 13, 2023

Insider trading activity of Asam Alexander

Transactions on record: 1; since Feb 13, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 13, 2023

Figures computed from official regulatory filings — methodology.

Companies where Asam Alexander has traded

Mineralys Therapeutics, Inc.1 tx · Feb 13, 2023

Track record of Asam Alexander

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Asam Alexander

Co-insiders of Asam Alexander

AKKARAJU SRINIVASMineralys Therapeutics, Inc.
Bain Capital Life Sciences Fund, L.P.Arcutis Biotherapeutics, Inc.
Bain Capital Life Sciences Investors, LLCArcutis Biotherapeutics, Inc.
Bain Capital Life Sciences Partners, LPArcutis Biotherapeutics, Inc.
BCIP Life Sciences Associates, LPArcutis Biotherapeutics, Inc.
Burnett PatrickArcutis Biotherapeutics, Inc.
Burrows Scott LArcutis Biotherapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Catalys Pacific Fund, LPMineralys Therapeutics, Inc.

CHAUDHURI BHASKARArcutis Biotherapeutics, Inc.

Congleton JonMineralys Therapeutics, Inc.

Curran TerrieArcutis Biotherapeutics, Inc.

DiRocco DerekMineralys Therapeutics, Inc.

Edwards Larry ToddArcutis Biotherapeutics, Inc.

ESTES DANIELArcutis Biotherapeutics, Inc.

FHM LIFE SCIENCES VIII, L.L.C.Arcutis Biotherapeutics, Inc.

FHM LIFE SCIENCES VIII, L.P.Arcutis Biotherapeutics, Inc.

Frazier Life Sciences VIII, L.P.Arcutis Biotherapeutics, Inc.

Gilbert Halley EArcutis Biotherapeutics, Inc.

Gold Alexander MMineralys Therapeutics, Inc.

HBM BIOVENTURES CAYMAN LTDMineralys Therapeutics, Inc.

Heron Patrick JArcutis Biotherapeutics, Inc.

Karydas DaphneMineralys Therapeutics, Inc.

Kolchinsky PeterMineralys Therapeutics, Inc.

Koppel AdamArcutis Biotherapeutics, Inc.

Krishnamohan NehaArcutis Biotherapeutics, Inc.

Leonard Keith RArcutis Biotherapeutics, Inc.

Levy Adam ScottMineralys Therapeutics, Inc.

LIN SUE-JEANArcutis Biotherapeutics, Inc.

Litzka OlivierMineralys Therapeutics, Inc.

Lock Kenneth A.Arcutis Biotherapeutics, Inc.

Matsuda MasaruArcutis Biotherapeutics, Inc.

Moore Matthew RichardArcutis Biotherapeutics, Inc.

Munshi AmitArcutis Biotherapeutics, Inc.

ORBIMED ADVISORS LLCArcutis Biotherapeutics, Inc.

OrbiMed Capital GP VII LLCArcutis Biotherapeutics, Inc.

ORBIMED CAPITAL LLCArcutis Biotherapeutics, Inc.

OSBORNE DAVID WArcutis Biotherapeutics, Inc.

RA Capital Biotech Fund LPMineralys Therapeutics, Inc.

RA CAPITAL MANAGEMENT, LLCMineralys Therapeutics, Inc.

RA Capital Nexus Fund III, L.P.Mineralys Therapeutics, Inc.

Rodman David MalcomMineralys Therapeutics, Inc.

Samsara BioCapital GP, LLCMineralys Therapeutics, Inc.

Samsara BioCapital, L.P.Mineralys Therapeutics, Inc.

SBLENDORIO GLENNMineralys Therapeutics, Inc.

Schwartz Jeffrey LawrenceArcutis Biotherapeutics, Inc.

Shah Rajeev M.Mineralys Therapeutics, Inc.

SILVERSTEIN JONATHANArcutis Biotherapeutics, Inc.

Slingsby Brian TaylorMineralys Therapeutics, Inc.

Smither John WArcutis Biotherapeutics, Inc.

Sun RickyArcutis Biotherapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Mineralys Therapeutics, Inc.	Feb 13, 2023	AwardD	44,000	0.00 USD	$0	SEC